You are using an outdated browser. Please upgrade your browser to improve your experience.

golimumab

Ligand Summary
Description
Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally well tolerated in patients with an inadequate response to MTX.
Synonyms & Links
ChEMBL: CHEMBL1201833
DrugCentral: 4967
LyCHI:  golimumab


Target Activities